Impairment Loss on Facilities Scheduled for Sale
First written in FY2017-Q1. 28 of 34 entries say "Restated". Latest entry: 2026-08-03.
Noevir Holdings moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).
The whole theme swung hardest in 2025: 16 of 29 companies on the "Worse" side.
0 other companies' latest entry also says "Cited as achieved".
- 2026-08-03Cited as achievedResults
「なお、当該減損損失の計上額は、当第3四半期連結累計期間においては「医薬・食品事業」120百万円でありました。」
売却することとなった土地に係る医薬・食品事業の減損損失120百万円を、第3四半期累計の実績として改めて記載している。 - FY2026-H1MaterialisedAnnual report
「The carrying amount of land designated for sale was reduced to its recoverable amount, and the reduction was recognized as an impairment loss. The impairment loss recognized during the interim consolidated accounting period was ¥120 million in the Pharmaceuticals and Food Business.」
An impairment loss of ¥120 million was recognized in the Pharmaceuticals and Food Business for land scheduled for sale. - 2026-05-13MaterialisedResults
「売却することとなった土地について、帳簿価額を回収可能価額まで減額し、当該減少額を減損損失に計上しております。」
売却する土地について減損損失が実際に発生し、医薬・食品事業で120百万円を計上している。 - FY2025RestatedAnnual report
「Information on impairment losses on fixed assets by reportable segment Not applicable.」
No new impairment losses on fixed assets related to the reporting segments are reported for the current fiscal year either. - FY2025-H1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The interim consolidated accounting period contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items related to the reporting segments. - FY2024RestatedAnnual report
「Information on impairment losses on fixed assets by reportable segment Not applicable.」
No new impairment losses on fixed assets related to the reporting segments are reported for the current fiscal year either. - FY2024-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative second quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items related to the reporting segments. - FY2024-Q1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative first quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items related to the reporting segments. - FY2023RestatedAnnual report
「Current consolidated fiscal year (from 1 October 2022 to 30 September 2023) There are no applicable matters.」
No new impairment losses on fixed assets related to the reporting segments were recognized for the current fiscal year either. - FY2023-Q3RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative third quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items related to the reporting segments. - FY2023-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The reporting-segment information for the cumulative second quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items. - FY2023-Q1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The reporting-segment information for the cumulative first quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items. - FY2022RestatedAnnual report
「During the current consolidated fiscal year, the carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses.」
The recognition of impairment losses on facilities scheduled for sale was also confirmed for the full fiscal year, with impairment losses totaling ¥310 million. - FY2022-Q3MaterialisedAnnual report
「The carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses. The impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year were ¥276 million in the Cosmetics Business, ¥27 million in the Pharmaceuticals and Food Business, and ¥6 million in Other Businesses.」
Total impairment losses of ¥309 million were recognized for facilities scheduled for sale, confirming the occurrence of new impairment losses following the previous “no applicable matters” disclosure. - FY2022-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative second quarter of the current consolidated fiscal year also contains no new disclosures concerning impairment losses on fixed assets or similar items related to the reporting segments. - FY2021RestatedAnnual report
「Information on impairment losses on fixed assets by reportable segment Not applicable.」
No new impairment losses on fixed assets related to the reporting segments are reported for the current fiscal year either. - FY2021-Q3RestatedAnnual report
「None applicable.」
The segment information for the cumulative third quarter of the current consolidated fiscal year contains no new disclosures concerning impairment losses on fixed assets or goodwill and similar items. - FY2021-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative second quarter of the current consolidated fiscal year also does not report any new impairment losses on fixed assets related to the segments. - FY2021-Q1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative first quarter of the current consolidated fiscal year also does not report any new impairment losses on fixed assets related to the segments. - FY2020RestatedAnnual report
「Information on impairment losses on fixed assets by reporting segment There are no applicable matters.」
No new impairment losses on fixed assets related to the segments are reported for the current fiscal year either. - FY2020-Q3RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative third quarter of the current consolidated fiscal year also does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2020-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative second quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2020-Q1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative first quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2019-Q3RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The cumulative third quarter of the current consolidated fiscal year also does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2019-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative second quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2019-Q1RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative first quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2018RestatedAnnual report
「Current consolidated fiscal year (from 1 October 2017 to 30 September 2018) There are no applicable matters.」
No new impairment losses related to facilities scheduled for sale were recognized for the full fiscal year either. - FY2018-Q3RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative third quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2018-Q2RestatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the cumulative second quarter of the current consolidated fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2018-Q1MitigatedAnnual report
「2 Information on impairment losses on property, plant and equipment or goodwill, etc., by reporting segment Not applicable.」
The segment information for the first quarter of the current fiscal year does not report any new impairment losses on fixed assets related to facilities scheduled for sale. - FY2017RestatedAnnual report
「During the current consolidated fiscal year, the carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses.」
The recognition of ¥199 million in impairment losses related to facilities scheduled for sale is also confirmed for the full fiscal year. - FY2017-Q3RestatedAnnual report
「In the Cosmetics Business and the Pharmaceuticals and Food Business, the carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses. The impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year were ¥189 million in the Cosmetics Business and ¥10 million in the Pharmaceuticals and Food Business.」
The recognition of ¥199 million in impairment losses related to facilities scheduled for sale is also reported for the cumulative third quarter of the current consolidated fiscal year. - FY2017-Q2RestatedAnnual report
「In the Cosmetics Business and the Pharmaceuticals and Food Business, the carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses. The impairment losses recognized during the cumulative second quarter of the current consolidated fiscal year were ¥189 million in the Cosmetics Business and ¥10 million in the Pharmaceuticals and Food Business.」
The recognition of ¥199 million in impairment losses related to facilities scheduled for sale is also reported for the cumulative second quarter of the current consolidated fiscal year. - FY2017-Q1MaterialisedAnnual report
「In the Cosmetics Business and the Pharmaceuticals and Food Business, the carrying amounts of land, buildings and other assets at facilities designated for sale were reduced to their recoverable amounts, and the reductions were recognized as impairment losses. The impairment losses recognized during the cumulative first quarter of the current consolidated fiscal year were ¥189 million in the Cosmetics Business and ¥10 million in the Pharmaceuticals and Food Business.」
The carrying amounts of facilities scheduled for sale were reduced to their recoverable amounts, and total impairment losses of ¥199 million were recognized.